A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

This study has been completed.
Information provided by (Responsible Party):
Celldex Therapeutics ( CuraGen Corporation )
ClinicalTrials.gov Identifier:
First received: December 18, 2006
Last updated: February 2, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: February 2, 2015